Target directed chemotherapy of tumours of the sexual organs
申请人:Forster Heinz
公开号:US20070099876A1
公开(公告)日:2007-05-03
The invention relates to dialkyltriazene-bearing estrogens and anti-estrogens that are suited for use as chemotherapeutic drugs for treating carcinomas of the sexual organs of humans and animals.
Microrna modulators and method for identifying and using the same
申请人:Huang Qihong
公开号:US20100196357A1
公开(公告)日:2010-08-05
The present invention is a method for identifying agents which modulate microRNA activity. The invention involves contacting a cell harboring a microRNA and a microRNA binding sequence, which is operably linked to a nucleic acid molecule encoding a reporter protein, with a test agent and determining whether the test agent increases or decreases the expression of the reporter protein thereby identifying a microRNA modulator. Antagonists identified by this screening assay are provided, as are methods for using the same to inhibit microRNA activity and prevent or treat disease.
MicroRNA Modulators and Method for Identifying and Using the Same
申请人:Huang Qihong
公开号:US20100317628A1
公开(公告)日:2010-12-16
The present invention is a method for identifying agents which modulate microRNA activity. The invention involves contacting a cell harboring a microRNA and a microRNA binding sequence, which is operably linked to a nucleic acid molecule encoding a reporter protein, with a test agent increases or decreases the expression of the reporter protein thereby identifying a microRNA modulator. Antagonists identified by this screening assay are provided, as are methods for using the same to inhibit microRNA activity and prevent or treat disease.
US8338392B2
申请人:——
公开号:US8338392B2
公开(公告)日:2012-12-25
[EN] MICRORNA MODULATORS AND METHOD FOR IDENTIFYING AND USING THE SAME<br/>[FR] MODULATEURS DE MICRO-ARN ET PROCÉDÉ D'IDENTIFICATION ET D'UTILISATION ASSOCIÉ
申请人:WISTAR INST
公开号:WO2010051048A1
公开(公告)日:2010-05-06
The present invention is a method for identifying agents which modulate microRNA activity. The invention involves contacting a cell harboring a microRNA and a microRNA binding sequence, which is operably linked to a nucleic acid molecule encoding a reporter protein, with a test agent and determining whether the test agent increases or decreases the expression of the reporter protein thereby identifying a microRNA modulator. Antagonists identified by this screening assay are provided, as are methods for using the same to inhibit microRNA activity and prevent or treat disease.